Research lays the groundwork for a lifesaving group B strep vaccine
One in five pregnant women carry Streptococcus agalactiae (group B strep or GBS) in the vaginal tract, which is typically harmless—except when it isn't.
Nov 22, 2023
0
0
One in five pregnant women carry Streptococcus agalactiae (group B strep or GBS) in the vaginal tract, which is typically harmless—except when it isn't.
Nov 22, 2023
0
0
Researchers at Cleveland Clinic have identified a new way that the SARS-CoV-2 virus hijacks its host's translation machinery using elements within its genetic material and causes COVID-19, paving the way for future study.
Nov 14, 2023
0
14
Hepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, HBV remains a leading ...
Nov 13, 2023
0
0
UCLA scientists have developed a new method to engineer more powerful immune cells that can potentially be used for "off-the-shelf" cell therapy to treat challenging cancers.
Nov 8, 2023
0
84
Gene therapy adeno-associated viruses (AAVs)—viruses that can be engineered to deliver DNA to target cells—are unlikely to cause cancer-triggering insertions in humans or monkeys and may contribute to long-term efficacy, ...
Nov 6, 2023
0
17
Underlying evolutionary dynamics could play a key role in the replication and progress of the chikungunya virus, a mosquito-borne viral disease. New research from Ph.D. student Wern Hann Ng, Dr. Xiang Liu and Professor Suresh ...
Oct 27, 2023
0
27
Severe combined immunodeficiencies (SCIDs) are a group of debilitating primary immunodeficiency disorders, primarily caused by genetic mutations that disrupt T-cell development. SCID can also affect B-cell and natural killer ...
Oct 27, 2023
0
53
Allogeneic invariant natural killer T cells (allo-iNKTs) from a healthy donor have been shown to have therapeutic effects in treatment-resistant cancers and improve survival from COVID-19-related acute respiratory failure ...
Oct 20, 2023
0
24
A new study led by Luísa Figueiredo, group leader at the Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal), and published in Nature Microbiology found a new strategy by the host to cope with Trypanosoma ...
Oct 12, 2023
0
37
Emory Vaccine Center researchers say they have identified the Achilles heel of SARS-CoV-2, the virus that causes COVID-19.
Sep 26, 2023
0
82